Caves, Clusters, and Weak Ties: The Six Degrees World of Inventors
Your company’s scientists and investors can be antennas that bring great ideas into your company. The key, says Associate Professor Lee Fleming, is understanding small-world networks.
The New CEO’s Wrong Message
Any new CEO who tries to wield power unilaterally will pay for it, say Professors Michael Porter, Jay Lorsch, and Nitin Nohria in this excerpt from the October 2004 Harvard Business Review.
Bypass Marketing: Are Docs Influenced?
Although they are prescription drugs, Viagra, Prozac, Allegra, and many others are pitched directly to consumers. Do physicians take notice? Professor Emeritus Alvin Silk and Harvard’s Joel Weissman discuss a recent study.
The Changing Roles of Doctors and Patients
Richard Bohmer, a physician as well as an HBS assistant professor, says doctors are becoming systems managers for patients who are increasingly willing and able to care for their own conditions. The result: changing models of health-care delivery.
The Bias of Wall Street Analysts
Historically, stock analysts’ recommendations have been swayed by business relationships between the analyst’s employer and the target company, says Assistant Professor Mark Bradshaw. Read an interview about an article he cowrote with two others in the June 2004 issue of Investor Relations Quarterly.
